Safety and efficacy of tirofiban in the management of stroke: A systematic review and meta-analysis of randomized controlled trials

[1]  Zhihui Duan,et al.  The efficacy and safety of intravenous tirofiban in the treatment of acute ischemic stroke patients with early neurological deterioration , 2022, Journal of clinical pharmacy and therapeutics.

[2]  Yan Zhang,et al.  Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis , 2022, Frontiers in Neurology.

[3]  Ya-Li Zheng,et al.  Efficacy and safety of tirofiban in patients with acute ischemic stroke without large-vessel occlusion and not receiving intravenous thrombolysis: A randomized controlled open-label trial , 2022, Journal of Neurorestoratology.

[4]  Tao Li,et al.  Early tirofiban administration for patients with acute ischemic stroke treated with intravenous thrombolysis or bridging therapy: Systematic review and meta-analysis , 2022, Clinical Neurology and Neurosurgery.

[5]  Jie Yang,et al.  Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial. , 2022, JAMA.

[6]  Xintong Liu,et al.  Continuous intravenous tirofiban can improve the 90-day functional outcome and decrease 90-day mortality without increasing bleeding risk in acute ischemic stroke patients treated by endovascular therapy: A meta-analysis , 2022, Journal of Clinical Neuroscience.

[7]  Weiwei Tan,et al.  Efficacy and Safety of Tirofiban in Clinical Patients With Acute Ischemic Stroke , 2022, Frontiers in Neurology.

[8]  Tianlong Liu,et al.  Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke , 2021, BMC Neurology.

[9]  F. Lin,et al.  Assessing the Efficacy and Safety of Tirofiban in Combination With Dual-antiplatelet Therapy in Progressive Ischemic Stroke Patients , 2021, Journal of Cardiovascular Pharmacology.

[10]  Y. Lee,et al.  Intravenous Tirofiban Infusion After Angioplasty and Stenting in Intracranial Atherosclerotic Stenosis-Related Stroke , 2021, Stroke.

[11]  Lisha Tang,et al.  The Application of Tirofiban in the Endovascular Treatment of Acute Ischemic Stroke: A Meta-Analysis , 2021, Cerebrovascular Diseases.

[12]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[13]  Lian-bo Gao,et al.  Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Receiving Endovascular Treatment: A Meta-Analysis , 2020, Cerebrovascular Diseases.

[14]  F. Gao,et al.  Safety and Efficacy of Tirofiban During Mechanical Thrombectomy for Stroke Patients with Preceding Intravenous Thrombolysis , 2020, Clinical interventions in aging.

[15]  J. Zhou,et al.  Safety and efficacy of tirofiban in acute ischemic stroke patients not receiving endovascular treatment: a systematic review and meta-analysis. , 2020, European review for medical and pharmacological sciences.

[16]  Zhiqiang Sun,et al.  Tirofiban for acute ischemic stroke: systematic review and meta-analysis , 2020, European Journal of Clinical Pharmacology.

[17]  X. Ji,et al.  Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis. , 2019, Stroke.

[18]  J. Zou,et al.  Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke , 2019, European journal of neurology.

[19]  Yongjun Wang,et al.  Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke , 2019, Drugs.

[20]  W. Powers,et al.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2018, Stroke.

[21]  D. Liebeskind,et al.  Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy , 2017, Stroke.

[22]  W. Feng,et al.  Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients , 2016, Stroke.

[23]  D. Liebeskind,et al.  Impact of Target Arterial Residual Stenosis on Outcome After Endovascular Revascularization , 2016, Stroke.

[24]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[25]  D. Mikulis,et al.  Vessel Wall Magnetic Resonance Imaging in Acute Ischemic Stroke: Effects of Embolism and Mechanical Thrombectomy on the Arterial Wall , 2014, Stroke.

[26]  W. Hacke,et al.  Endovascular Stroke Therapy: Tirofiban Is Associated With Risk of Fatal Intracerebral Hemorrhage and Poor Outcome , 2013, Stroke.

[27]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[28]  O. Witte,et al.  Safety of Tirofiban in Acute Ischemic Stroke: The SaTIS Trial , 2011, Stroke.

[29]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[30]  J. Ottervanger,et al.  Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial , 2008, The Lancet.

[31]  J. Fullard.  The role of the platelet glycoprotein IIb/IIIa in thrombosis and haemostasis. , 2004, Current pharmaceutical design.

[32]  Dong Ik Kim,et al.  Immediate reocclusion following a successful thrombolysis in acute stroke: A pilot study , 2003, Neurology.

[33]  E. Connolly,et al.  Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. , 1998, The Journal of clinical investigation.

[34]  E. Topol,et al.  Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. , 1995, The New England journal of medicine.

[35]  Jian Li,et al.  Tirofiban improves rehabilitation therapeutics effects in patients with dyskinesia after stroke , 2018 .

[36]  I. Piña,et al.  Professionals From the American Heart Association / American Stroke Association Guidelines for the Prevention of Stroke in Women : A Statement for Healthcare , 2014 .